CD8A and neoplasm: Certain peripheral and tumor‐infiltrating immune cells, such as NK cells, CD3 + T cells, CD8 + T cells, and Foxp3 + Tregs, that are reportedly correlated with better gastric cancer prognoses, have been recommended for predicting prognosis and assessing therapeutic outcomes at the clinical level.18, 19